SCM
TEVA icon

Snow Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Snow Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-63,752
Closed -$2.12M – 133
2017
Q2 		$2.12M Sell
63,752
-9,475
-13% -$293K 0.11% 77
2017
Q1 		$2.35M Sell
73,227
-118,476
-62% -$4.04M 0.11% 86
2016
Q4 		$6.95M Sell
191,703
-774,283
-80% -$30.9M 0.31% 57
2016
Q3 		$44.4M Sell
965,986
-110,053
-10% -$5.74M 2% 23
2016
Q2 		$54M Sell
1,076,039
-66,884
-6% -$3.56M 2.54% 11
2016
Q1 		$61.2M Sell
1,142,923
-119,427
-9% -$7.01M 2.7% 12
2015
Q4 		$82.9M Sell
1,262,350
-115,642
-8% -$7.15M 3.3% 5
2015
Q3 		$77.8M Sell
1,377,992
-225,316
-14% -$14.6M 2.78% 9
2015
Q2 		$94.8M Sell
1,603,308
-204,111
-11% -$12.6M 2.77% 11
2015
Q1 		$113M Sell
1,807,419
-49,309
-3% -$2.87M 3.5% 3
2014
Q4 		$107M Buy
1,856,728
+60,229
+3% +$3.36M 3.2% 8
2014
Q3 		$96.6M Sell
1,796,499
-30,300
-2% -$1.61M 3.35% 8
2014
Q2 		$95.8M Buy
1,826,799
+117,909
+7% +$6.03M 3.32% 6
2014
Q1 		$90.3M Sell
1,708,890
-267,941
-14% -$12.4M 3.54% 3
2013
Q4 		$79.2M Buy
1,976,831
+549,809
+39% +$21.6M 3.22% 6
2013
Q3 		$53.9M Buy
1,427,022
+61,548
+5% +$2.4M 2.41% 20
2013
Q2 		$53.5M Buy
+1,365,474
New +$53.2M 2.48% 17

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Snow Capital Management's TEVA Position: Q3 2017 in Review

Snow Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 63,752 shares — an estimated $2.12M sold.

Snow Capital Management first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $113M in Q1 2015. 536 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Snow Capital Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Snow Capital Management sold 63,752 Teva Pharmaceuticals shares in Q3 2017, an estimated $2.12M.
  • Snow Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Snow Capital Management's Teva Pharmaceuticals position peaked at $113M in Q1 2015.
  • 536 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Snow Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.